Clinical Trial

Dexmedetomidine-Midazolam vs. Ketamine-Midazolam on Emergence Delirium

Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
Fifty children undergoing heart catheterization without local anesthesia in the skin will be randomly divided into two groups. Group DM (Dexmedetomidine + Midazolam) and Group KM (Ketamine + Midazolam)
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-02-17.
Trial Details
NCT Number NCT07427446
Lead Sponsor Kasr El Aini Hospital
Conditions Emergence Delirium
Enrollment 50 participants
Start Date 2026-02-01
Primary Completion 2026-12 (estimated)
Study Completion 2027-03 (estimated)
Updated on ClinicalTrials.gov 2026-02-27